- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05192187
Why do People With Low Back Pain Fear and Avoid Lifting?
January 28, 2022 updated by: Thomas Matheve, Hasselt University
The investigators' main focus of this trial will be to investigate
- why people with low back pain perceive lifting (with a bent back) as harmful.
- whether general measures of pain-related fear are associated with task-specific measures of perceived harmfulness
- why people with low back pain avoid lifting (with a bent back) This will be investigated using self-report (i.e., questionnaires)
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
325
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Thomas Matheve, PhD
- Phone Number: 32(0)11 28 69 39
- Email: Thomas.Matheve@uhasselt.be
Study Locations
-
-
-
Hasselt, Belgium, 3500
- Hasselt University
-
Contact:
- Lotte Janssens, PhD
- Email: lotte.janssens@uhasselt.be
-
Contact:
- Thomas Matheve, PhD
- Email: Thomas.Matheve@uhasselt.be
-
Principal Investigator:
- Thomas Matheve, PhD
-
Principal Investigator:
- Lotte Janssens, PhD
-
Principal Investigator:
- Katleen Bogaerts, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- low back pain >3 months
Exclusion Criteria:
- healthy persons
- low back pain <3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: LBP
This group will be asked to complete self-reported questionnaires on a single occasion (cross-sectional)
|
participants in this group will be ask to complete questionnaires on one occasion (i.e., cross-sectional investigation). The questionnaires will consist of a self-developed questionnaire and standard questionnaires. The main aspects of the self-developed questionnaires are
Standardised questionnaires include
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
cognitions about perceived harmfulness and avoidance of lifting
Time Frame: Day 1 (cross-sectional study)
|
cognitions about perceived harmfulness and avoidance of lifting using self-developed questionnaires.
Questions will be scored on a 1-5 Likert scale (1= completely disagree, 5= completely agree)
|
Day 1 (cross-sectional study)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain-related fear
Time Frame: Day 1 (cross-sectional study)
|
Tampa Scale for Kinesiophobia 11-item version questionaire (range= 11-44.
Higher score = higher levels of pain-related fear)
|
Day 1 (cross-sectional study)
|
perceived harmfulness of specific tasks
Time Frame: Day 1 (cross-sectional study)
|
perceived harmfulness of specific tasks measured with a selection of pictures of the Photographs of Daily Activities - Short Electronic version.
Each picture will be scored on a 0-100 scale, with higher scores indicating higher levels of perceived harmfulness
|
Day 1 (cross-sectional study)
|
Disability
Time Frame: Day 1 (cross-sectional study)
|
Roland Morris Disability Questionnaire (score range= 0-24, higher score= higher level of disbility)
|
Day 1 (cross-sectional study)
|
Task-specific self-efficacy
Time Frame: Day 1 (cross-sectional study)
|
For different tasks, participants will be asked to rate the task-specific self-efficacy on a 0-10 Visual analogue scale (higher scores= higher levels of self-efficacy)
|
Day 1 (cross-sectional study)
|
Task-specific disability
Time Frame: Day 1 (cross-sectional study)
|
For different tasks, participants will be asked to rate their perceived disability on a 0-10 Visual analogue scale (higher scores= higher levels of disability)
|
Day 1 (cross-sectional study)
|
Pain-related fear
Time Frame: Day 1 (cross-sectional study)
|
Fear-Avoidance Beliefs Questionnaire.
The Activity Avoidance Subscale (score range= 0-24) and Work subscale (score range= 0-42) will both be used.
Higher scores indicate higher levels of pain-related fear
|
Day 1 (cross-sectional study)
|
Pain intensity
Time Frame: Day 1 (cross-sectional study)
|
Numeric rating scale (0-10, higher score= higher level of pain)
|
Day 1 (cross-sectional study)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Age
Time Frame: Day 1 (cross-sectional study)
|
years
|
Day 1 (cross-sectional study)
|
Sex
Time Frame: Day 1 (cross-sectional study)
|
Male, female, other
|
Day 1 (cross-sectional study)
|
Physical job requirements
Time Frame: Day 1 (cross-sectional study)
|
Questionnaire (derived from de Dutch Musculoskeletal Questionnaire) asking about physical job requirements
|
Day 1 (cross-sectional study)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Thomas Matheve, PhD, Hasselt University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
February 1, 2022
Primary Completion (Anticipated)
June 30, 2023
Study Completion (Anticipated)
December 31, 2023
Study Registration Dates
First Submitted
December 22, 2021
First Submitted That Met QC Criteria
December 30, 2021
First Posted (Actual)
January 14, 2022
Study Record Updates
Last Update Posted (Actual)
February 2, 2022
Last Update Submitted That Met QC Criteria
January 28, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ThomasMatheve-2021-3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low Back Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
University School of Physical Education in WroclawCompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, PosturalPoland
-
Texas Woman's UniversityTexas Physical Therapy AssociationCompletedLow Back Pain | Chronic Low Back Pain | Subacute Low Back PainUnited States
-
University of ParmaKing's College London; Helmholtz Zentrum München; GENOS; Ip Research Consulting... and other collaboratorsUnknownChronic Low Back Pain | Acute Low Back PainUnited States, Australia, Belgium, Croatia, Italy, United Kingdom
-
Ache Laboratorios Farmaceuticos S.A.Unknown
-
Palmer College of ChiropracticDepartment of Health and Human ServicesCompletedChronic Low Back Pain | Subacute Low Back PainUnited States
-
Universität Duisburg-EssenSiemens-BetriebskrankenkasseCompletedChronic Low Back Pain | Recurrent Low Back Pain
-
Karolinska InstitutetCompletedChronic Low Back Pain | Recurrent Low Back Pain | Persistent Low Back PainSweden
-
Apsen Farmaceutica S.A.CompletedLow Back Pain | Low Back Pain, Mechanical | Acute Low Back PainBrazil
Clinical Trials on Cross-sectional self-report (questionnaires)
-
Universitätsklinikum Hamburg-EppendorfActive, not recruitingCarcinoma | Palliative Care | Neoplasms MalignantGermany
-
Assistance Publique - Hôpitaux de ParisCompletedParenteral NutritionFrance
-
Vrije Universiteit BrusselRecruiting
-
University of KielRecruiting
-
Assistance Publique - Hôpitaux de ParisPr Joel COSTE, Hôpital Hôtel Dieu - Unité de Bio Statistiques et Epidémiologiques...CompletedCOPD (With - Without Rehabilitation) | Diffuse Interstitial Lung Diseases | Pulmonary Arterial Hypertension Primary or Secondary (Post Embolic .....) | Cystic Fibrosis of the AdultFrance
-
Sophiahemmet UniversityKarolinska Institutet; ForteActive, not recruiting
-
University of LiegeKU LeuvenCompletedPeriodontitis | Dentulous | Abdominal Aorta Aneurism
-
Centre Hospitalier de CayenneCompleted
-
Mutah UniversityRecruitingFibromyalgia | Orthopedic DisorderJordan
-
Charite University, Berlin, GermanyCompletedCovid19 | Influenza A | Respiratory DiseaseGermany